首页|期刊导航|北京中医药大学学报|代谢相关脂肪性肝病"三期三维"诊疗体系构建与临床应用

代谢相关脂肪性肝病"三期三维"诊疗体系构建与临床应用OA

Establishment and clinical application of the"three-stage and three-dimension"diagnosis and treatment system for metabolic-associated fatty liver disease

中文摘要英文摘要

代谢相关脂肪性肝病(MAFLD)作为全球高发的慢性肝病,其疾病谱系呈现从单纯性脂肪肝、脂肪性肝炎到肝纤维化/肝硬化的动态演进特征.西医学虽已阐明其"多重打击"发病机制,但仍缺乏特效治疗手段,目前主要依赖生活方式干预和有限的药物治疗,难以有效阻断疾病进展;中医传统静态辨证模式虽聚焦痰湿、血瘀等病理因素,但在系统把握该病从功能性失调到器质性损伤的复杂动态演变过程方面仍存在一定局限,导致临床防治效果受限.本研究提出 MAFLD"由郁至损"的核心病机演化规律,明确疾病循"郁(气机郁滞)→热(浊毒化热)→损(肝损癥积)"三阶段动态传变.构建"三期三维"立体病机模型,纵向以"郁期、热期、损期"刻画疾病时序演进,横向从"脏腑功能、病理因素、络脉状态"三个维度解析各阶段核心靶点,形成时空一体的病机分析体系.据此创立"疏肝、清肝、养肝"的"调肝三部曲"分期诊疗体系并明确了各期的代表方药.本研究构建的"三期三维"诊疗体系,实现了病机认识、辨证分型、治则治法与方药应用的有机统一,为MAFLD 的中西医结合精准防治提供了全新的理论框架和临床路径,旨在有效阻断疾病进展、改善患者预后,解决该病临床分期不清、辨证不精、治疗靶向性不足的实际问题.

Metabolic-associated fatty liver disease(MAFLD),a globally prevalent chronic liver disorder,is characterized by a dynamically progressive disease spectrum spanning simple hepatic steatosis,steatohepatitis,and hepatic fibrosis/cirrhosis.Although Western medicine has clarified its"multiple hits"pathogenesis,specific therapeutic strategies for MAFLD are lacking and primarily rely on lifestyle interventions and limited medications and pharmacotherapies.Although the traditional syndrome differentiation of Chinese medicine focuses on pathological factors,such as phlegm-dampness and blood stasis,it has certain limitations in systematically capturing the complex dynamic evolutionary process of this disease from functional disorder to organic damage,thereby limiting its clinical efficacy in prevention and treatment.This study proposes a core pathogenesis evolution law of MAFLD characterized by stagnation to impairment.It clarifies that the disease undergoes a three-stage dynamic progression following the stagnation pathway(qi movement stagnation)→ heat(turbid toxin transforming into heat)→impairment(hepatic injury with fibrosis and mass formation).Our team have established a three-stage and three-dimension stereoscopic pathogenesis model,in which the vertical dimension delineates the temporal progression of the disease through the stagnation,heat,and impairment stages,and the horizontal dimension deciphers the core targets of each stage from three aspects:zang-fu viscera function,pathological factors,and collateral status,forming a spatiotemporally integrated pathogenesis analysis system.On this basis,we established a stage-specific diagnosis and treatment system featuring a three-step liver modulation strategy of dispersing stagnated liver qi,removing liver-fire,and nourishing the liver.We identified the representative herbal formulas corresponding to each stage.This three-stage,three-dimension diagnosis and treatment system achieved organic integration of pathogenesis understanding,syndrome differentiation,therapeutic principles and methods,and herbal formula application.It provides a novel theoretical framework and clinical approach for integrating Chinese and Western medicine to prevent and treat MAFLD,aiming to halt disease progression,improve patient prognosis,and address practical clinical challenges such as ambiguous disease staging,imprecise syndrome differentiation,and insufficient therapeutic targeting.

胡佳艳;李军祥;毛堂友;王昱茜;林政道;蔚伊童;杨安琪

北京中医药大学东方医院 北京 100078||北京中医药大学研究生院北京中医药大学东方医院 北京 100078北京中医药大学东方医院 北京 100078北京中医药大学东方医院 北京 100078||北京中医药大学研究生院北京中医药大学东方医院 北京 100078||北京中医药大学研究生院北京中医药大学东方医院 北京 100078||北京中医药大学研究生院北京中医药大学东方医院 北京 100078||北京中医药大学研究生院

医药卫生

代谢相关脂肪性肝病中医药病机三期三维分期诊疗

metabolic-associated fatty liver diseasetraditional Chinese medicinepathogenesisthree-stage and three-dimensionphased diagnosis and treatment

《北京中医药大学学报》 2026 (4)

537-543,7

深圳市医学研究专项资金资助项目(No.C2401033)深圳市宝安区区属公立医院高质量发展研究项目(No.BAGZL2024129) Shenzhen Medical Research Special Fund(No.C2401033)

10.3969/j.issn.1006-2157.2026.04.011

评论